Scinovex
article Open AccessTop 1% cited

Cannabidiol displays unexpectedly high potency as an antagonist of CB<sub>1</sub>and CB<sub>2</sub>receptor agonists<i>in vitro</i>

British Journal of Pharmacology · 2007 · Vol. 150(5) · pp. 613–623
Adèle ThomasGemma L. BaillieAngela M. PhillipsRaj K. RazdanRuth A. RossRoger G. Pertwee

Abstract

This study has provided the first evidence that cannabidiol can display CB2 receptor inverse agonism, an action that appears to be responsible for its antagonism of CP55940 at the human CB2 receptor. The ability of cannabidiol to behave as a CB2 receptor inverse agonist may contribute to its documented anti-inflammatory properties.

Cannabis and Cannabinoid ResearchDiet, Metabolism, and DiseaseNeurotransmitter Receptor Influence on BehaviorCannabidiolInverse agonistCannabinoidPharmacologyCannabinoid receptorCannabinoid receptor type 2ReceptorAgonistChemistryCannabinoid receptor antagonist

MeSH terms

RimonabantAnimalsAnti-Inflammatory AgentsCamphanesBrainCannabidiolCell MembraneCricetulusCyclohexanesCyclohexanolsDose-Response Relationship, DrugCricetinaeHumansMice, Inbred C57BLMorpholines

Funding

  • GW Pharmaceuticals
  • Biotechnology and Biological Sciences Research Council
Citations
744
FWCI
18.31
field-weighted impact
References
28
Percentile
100%
vs. same field & year
Citations per year
Related articles
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Cannabidiol displays unexpectedly high potency as an antagonist of CB<sub>1</sub>and CB<sub>2</sub>receptor agonists<i>in vitro</i> · Scinovex